Evaluating the effect of galantamine HBr using Goal Attainment Scaling (GAS) in a placebo controlled trial of mild to moderate Alzheimer's disease subjects.

Projet: Research project

Détails sur le projet

StatutTerminé
Date de début/de fin réelle7/1/016/30/03

Financement

  • Institute of Aging: 294 052,00 $ US

ASJC Scopus Subject Areas

  • Clinical Neurology
  • Neurology
  • Medicine (miscellaneous)
  • Ageing